POTS, Small Intestine Bacterial Overgrowth (SIBO) and Low Dose Naltrexone (LDN)

In this podcast episode, Dr. Leonard Weinstock, a gastroenterologist, discusses the gastrointestinal issues commonly associated with syndromes like POTS, EDS, and MCAS, placing a particular emphasis on small intestine bacterial overgrowth (SIBO). Dr. Weinstock also explores the use of low dose naltrexone (LDN) as a part of his therapeutic regimen for these conditions. He delves into how SIBO can impact patients with these syndromes and the potential benefits of incorporating LDN into their management plans. For additional insights, listeners can access an article related to the discussion through the provided link.

Comorbidities Pharmacological Treatments
Published August 24, 2021
POTS, Small Intestine Bacterial Overgrowth (SIBO) and Low Dose Naltrexone (LDN)
Contributors
Source

The POTScast

Medical Disclaimer

The purpose of this website is to inform and educate only. The information provided here is not intended to serve as professional medical advice, diagnosis, or treatment.

If you have health related issues, please contact a qualified health professional to get the personalized assessment, advice, and treatment that you need.

The creators of this living library, documentary and/or website will not be liable for any direct, indirect, or other damages arising from the use of these resources.